AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will present at the Canaccord
Adams 29th Annual Growth Stock Conference in Boston on August
12, 2009 at 4:30 p.m. Eastern Time. Jan Keltjens, President and CEO, and
Joseph Gersuk, Executive Vice President and CFO of AngioDynamics, will
review the Company’s business strategy and historical financial results.
Attendance at the conference is by invitation only. Individuals can
listen to the live and archived presentation on the Internet by visiting
the investor relations portion of the Company’s website at: www.angiodynamics.com.
The archived presentation will be available for 90 days.
About AngioDynamics
AngioDynamics is a leading provider of innovative medical devices used
by interventional radiologists, surgeons and other physicians for the
minimally-invasive treatment of cancer and peripheral vascular disease.
The Company’s diverse product line includes market-leading
radiofrequency and irreversible electroporation ablation systems,
vascular access products, angiographic products and accessories,
dialysis products, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC
Group, Inc.
Doug Sherk or Jenifer Kirtland, 415-896-6820 (Investor
Relations)
dsherk@evcgroup.com
jkirtland@evcgroup.com
or
EVC
Group, Inc.
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com
